Point Guard Biosciences Announces Innovation in Ophthalmology Award

Oct 28, 2015, 10:34 ET from Point Guard Biosciences, LLC

TAMPA, Fla., Oct. 28, 2015 /PRNewswire/ -- Point Guard Biosciences, LLC (PGBio), a privately held ophthalmic-focused biopharmaceutical company, announced today that it is launching its inaugural PGBio Innovation in Ophthalmology Award.  This award is created by PGBio to support entrepreneurs in the area of ophthalmology by providing financial help as well as assistance with strategic planning.

"This award is focused on advancing innovative technologies currently in preclinical or early clinical stages of development that have application in critical areas of ophthalmology," says Barry Butler, CEO of Point Guard Biosciences. "Ideal projects for this award could include new drug delivery systems, novel pharmaceutical products, innovative medical devices, new diagnostic tools, or technology to improve clinical trials," he adds.

The award recipient will be chosen exclusively by the PGBio team based on novelty of the medical research, and the ability of the project to improve the quality of life of patients. The winner will be awarded a cash prize of $10,000. In addition to the cash prize, the award recipient will receive assistance from the PGBio team with the development of a business plan.

The submission deadline for this award is January 22nd 2016. The Award recipient will be announced on April 21st 2016.

For more information on how to apply, please visit our website: www.PointGuard.Bio

About Point Guard Biosciences
PGBio is devoted to finding, funding and developing innovative technologies in the areas of ophthalmic pharmaceuticals and medical devices.  The staff of PGBio has extensive experience developing ophthalmic products, raising venture capital and managing start-up companies. 

PGBio is a member of the Point Guard Partners (PGP) family of companies.  Other companies in the PGP family include Oculos Clinical Research, a full service ophthalmology-focused CRO and Oculos Consulting, which provides regulatory affairs and CMC consulting services to ophthalmic companies.

To learn more about all the companies in the PGP family, please visit our website: www.pointguardllc.com.

Contact:  Rosa Corrales, Ph. D

SOURCE Point Guard Biosciences, LLC